Fospropofol + Propofol/Lidocaine
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Complication of Injection
Conditions
Complication of Injection, Pain
Trial Timeline
Aug 1, 2010 → Jan 1, 2013
NCT ID
NCT01401049About Fospropofol + Propofol/Lidocaine
Fospropofol + Propofol/Lidocaine is a approved stage product being developed by Eisai for Complication of Injection. The current trial status is completed. This product is registered under clinical trial identifier NCT01401049. Target conditions include Complication of Injection, Pain.
What happened to similar drugs?
12 of 16 similar drugs in Complication of Injection were approved
Approved (12) Terminated (2) Active (3)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01401049 | Approved | Completed |
Competing Products
20 competing products in Complication of Injection